
City St George’s partners to develop new osteoarthritis drug
City St George’s is partnering with drug development company Paradigm Biopharmaceuticals to test a drug that could become a new treatment option for osteoarthritis. The UK-Australian partnership will investigate the effect of injectable pentosan polysulfate sodium (iPPS) – a drug currently being trialled for knee osteoarthritis by Paradigm Biopharmaceuticals… Read More
